Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Boehringer Ingelheim
AstraZeneca
Colorcon
Dow

Last Updated: December 2, 2022

Telavancin hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for telavancin hydrochloride and what is the scope of patent protection?

Telavancin hydrochloride is the generic ingredient in one branded drug marketed by Cumberland Pharms and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Telavancin hydrochloride has one hundred and twenty-eight patent family members in thirty-five countries.

One supplier is listed for this compound.

Summary for telavancin hydrochloride
International Patents:128
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 13
Clinical Trials: 15
Patent Applications: 23
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in telavancin hydrochloride?telavancin hydrochloride excipients list
DailyMed Link:telavancin hydrochloride at DailyMed
Recent Clinical Trials for telavancin hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Joseph KutiPhase 4
Theravance Biopharma, US, Inc.Phase 4
Joseph L. Kuti, PharmDPhase 4

See all telavancin hydrochloride clinical trials

Pharmacology for telavancin hydrochloride

US Patents and Regulatory Information for telavancin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cumberland Pharms VIBATIV telavancin hydrochloride POWDER;INTRAVENOUS 022110-002 Sep 11, 2009 RX Yes Yes See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Cumberland Pharms VIBATIV telavancin hydrochloride POWDER;INTRAVENOUS 022110-001 Sep 11, 2009 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cumberland Pharms VIBATIV telavancin hydrochloride POWDER;INTRAVENOUS 022110-002 Sep 11, 2009 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cumberland Pharms VIBATIV telavancin hydrochloride POWDER;INTRAVENOUS 022110-001 Sep 11, 2009 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cumberland Pharms VIBATIV telavancin hydrochloride POWDER;INTRAVENOUS 022110-002 Sep 11, 2009 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Cumberland Pharms VIBATIV telavancin hydrochloride POWDER;INTRAVENOUS 022110-001 Sep 11, 2009 DISCN Yes No See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for telavancin hydrochloride

International Patents for telavancin hydrochloride

Country Patent Number Title Estimated Expiration
Hungary 229370 GLYCOPEPTIDE PHOSPHONATE DERIVATIVES See Plans and Pricing
Australia 5981601 See Plans and Pricing
South Korea 20020093110 See Plans and Pricing
Poland 1678201 See Plans and Pricing
Brazil 0111222 See Plans and Pricing
South Korea 100856479 See Plans and Pricing
Hong Kong 1052191 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for telavancin hydrochloride

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1292612 122011100062 Germany See Plans and Pricing PRODUCT NAME: TELAVANCIN ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ HIERVON, EINSCHLIESSLICH TELAVANCINHYDROCHLORID; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902
1292612 132012902025885 Italy See Plans and Pricing PRODUCT NAME: TELAVANCINA(VIBATIV); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/11/705/001-002, 20110902
1292612 C 2012 002 Romania See Plans and Pricing PRODUCT NAME: TELAVANCIN SAU O SARE ACCEPTABILA FARMACEUTIC A ACESTUIAINCLUZAND CLORHIDRAT DE TELAVANCIN; NATIONAL AUTHORISATION NUMBER: RO EU/1/11/705/001, RO EU/1/11/705/002; DATE OF NATIONAL AUTHORISATION: 20110902; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/11/705/001, EU/1/11/705/002; DATE OF FIRST AUTHORISATION IN EEA: 20110902
1292612 PA2012002 Lithuania See Plans and Pricing PRODUCT NAME: TELAVANCINUM; REGISTRATION NO/DATE: EU/1/11/705/001, 2011 09 02 EU/1/11/705/002 20110902
1292612 417 Finland See Plans and Pricing
1292612 91908 Luxembourg See Plans and Pricing 91908, EXPIRES: 20260501
1292612 SPC/GB11/056 United Kingdom See Plans and Pricing PRODUCT NAME: TELAVANCIN, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING TELAVANCIN HYDROCHLORIDE; REGISTERED: UK EU/1/11/705/001 20110906; UK EU/1/11/705/002 20110906
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Boehringer Ingelheim
Merck
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.